You've put in the work. The biology just hasn't caught up.
Clinician-prescribed semaglutide and tirzepatide — the most
clinically validated fat loss compounds available — managed
remotely, delivered monthly.
†Published clinical trial data. Not AnthologyRX-specific outcomes. Individual results vary significantly. Results are not guaranteed.
GLP-1 receptor agonists — semaglutide and tirzepatide — represent the most clinically significant advance in metabolic medicine in a generation. These are not supplements or lifestyle tools. They are physician-prescribed compounds that directly modulate appetite signaling, insulin sensitivity, and fat metabolism at the cellular level.
GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the gut after eating. By mimicking and extending this signal, these compounds slow gastric emptying, reduce glucagon secretion, and act on hypothalamic receptors to suppress food noise — the background cognitive preoccupation with eating that undermines even the most disciplined approaches.
AnthologyRX puts the full clinical protocol in your hands: prescribing, licensed pharmacy fulfillment, ongoing provider management, and dosing adjustments — all remote, all on your schedule. Your intake takes minutes. Provider review completes within 48 hours.
Not a diet.
Not a supplement.
A clinical intervention.
Prescribed by a licensed physician.
Compounded by a 503B pharmacy.
Managed around your life.
The same pharmacology that achieved outcomes previously requiring bariatric surgery — available remotely, monthly, from $199.
Your provider will evaluate candidacy for both based on your intake and clinical history. Here's what the data says.
†STEP 1 trial. N=1,961. Results from published clinical data. Individual results vary.
†SURMOUNT-5. N=751. Phase 3b head-to-head vs. semaglutide. Individual results vary. Not a guarantee of outcomes.
Dosing is titrated to minimize lean mass loss. Your physician monitors body composition markers monthly and adjusts if needed. The goal is fat reduction, not muscle.
GLP-1 agonists improve insulin sensitivity, reduce fasting glucose, and support improvements in metabolic markers associated with excess body weight. These aren't cosmetic changes — they're systemic physiological shifts with documented long-term health implications.
By acting on hypothalamic satiety receptors, these compounds reduce hunger frequency and eliminate food noise — the background cognitive preoccupation with eating that undermines discipline. Patients routinely describe it as "thoughts about food just… stopping." That cognitive reclaim is measurable and significant.
Patients on conservatively dosed protocols consistently report preserved lean mass. Your physician monitors body composition markers monthly. If lean mass signals drift, dosing is adjusted. The goal is body recomposition — not just a lower number on a scale.
Your diet is dialed in and you stay active. Body composition has plateaued despite doing everything right. The protocol removes the metabolic ceiling that lifestyle alone can't clear — and your physician manages it around your schedule.
An injury, a demanding career season, or a life transition put weight on. You know how to work hard — you need clinical support to return to the body you know you're capable of, on a timeline that makes sense.
You treat health as a long-term priority. Body weight is a longevity variable, not a vanity metric. You want a physician-managed protocol, clinical data, and a provider who adjusts your dosing based on your labs — not a consumer wellness product.
Your intake screens for all contraindications. Every candidate is reviewed by a licensed physician before any prescription is issued. If you're borderline on any criteria, your provider will advise you directly — no guesswork.
A structured medical questionnaire — health history, current medications, goals, contraindication screening. Under five minutes. No video call. No waiting room. Completed entirely on your schedule.
A board-certified physician reviews your intake within 48 hours. They evaluate candidacy, review contraindications, and issue your prescription if approved. If not approved, you're notified immediately with clinical reasoning — no charge.
Your medication ships from a licensed 503B compounding pharmacy — temperature-controlled packaging, tracked delivery, direct to your door on the protocol's recurring schedule. No pharmacy visit. No insurance required.
Monthly provider check-ins, dosing adjustments based on your response and labs, and direct messaging access to your care team. Your protocol evolves as your body does. No auto-pilot — active clinical management throughout.
I've trained consistently for years. This protocol finally got the weight to match the effort. I kept my strength — hit a deadlift PR in week 10. The food noise going quiet was the part nobody warned me about. That alone changed everything.
I travel 200 days a year. I needed something that works without a perfect routine. The remote management was seamless — I barely had to think about it. Provider responded to my messages within hours. I've tried everything. This is different in kind, not degree.
Three weeks in, the food noise stopped. I didn't realize how much cognitive bandwidth I was burning on eating until it just disappeared. I'm a competitive cyclist — I kept every training block. The weight came off, the watts went up.
Individual results vary and are not typical. Testimonials reflect patient-reported outcomes and are used as illustrations only. In the STEP 1 trial, average weight reduction was 14.9% over 68 weeks. Results are not guaranteed. All patients are under licensed physician supervision.
Subscriptions renew monthly. Cancel anytime before your renewal date — no fees, no calls required. Provider review is required before any prescription is issued. All treatments require physician approval. Results vary. FSA/HSA eligibility depends on your individual plan.
No more than using a knee brace after an injury. GLP-1 agonists address a biological mechanism — specifically, how the hypothalamus regulates appetite and reward signaling. Obesity and metabolic resistance are not character failures. They're physiological conditions with pharmacological solutions. The discipline you've already applied is real. This protocol makes it land where it hasn't been able to.
Muscle loss is a real risk on any aggressive caloric restriction — including GLP-1. AnthologyRX protocols are specifically designed to minimize this: dosing is titrated conservatively, protein intake targets are built into your protocol, and your physician actively monitors composition markers. Patients on conservatively dosed protocols consistently report preserved — and in some cases improved — lean mass through the weight loss phase. If lean mass signals drift, your provider adjusts.
Clinical data shows some weight regain occurs in most patients who discontinue GLP-1 therapy without a maintenance protocol. AnthologyRX addresses this directly: as you approach your target, your physician will work with you on a structured tapering and maintenance plan — which may include a lower maintenance dose, a transition to other protocols, or a planned pause with active monitoring. The goal is a sustainable outcome, not a dependency cycle.
Semaglutide and tirzepatide are FDA-approved molecules. AnthologyRX dispenses these compounds through a licensed 503B compounding pharmacy, which operates under FDA oversight and Current Good Manufacturing Practice (cGMP) standards. Compounded medications are not FDA-approved as finished drug products — they are individually prescribed formulations prepared under federal and state regulations. Your prescription is issued by a licensed physician in your state.
The most common side effects are gastrointestinal — nausea, vomiting, diarrhea — and are predominantly concentrated during dose escalation. These are typically mild to moderate and resolve as your body adjusts. Your titration schedule is managed specifically to minimize this. Rare but serious risks include pancreatitis and, in individuals with a personal or family history of medullary thyroid carcinoma or MEN2, a potential thyroid risk (these are absolute contraindications, screened at intake). Your provider will review your full risk profile before prescribing.
Yes. AnthologyRX offers hormone optimization, NAD+, peptide, and MICC protocols designed with GLP-1 co-administration in mind. Your physician reviews all active medications and supplements during intake and advises on compatibility. Stacking is evaluated case-by-case — the objective is optimized clinical outcomes, not upsell volume. MICC lipotropic injections are particularly commonly combined with GLP-1 for patients focused on body composition.
Most patients who hit their GLP-1 goal still have work left to do — visceral fat that didn't move with the scale, or body composition that needs refinement. AnthologyRX protocols are designed to stack. Here's what comes next.
GLP-1 drives systemic weight loss. Tesamorelin targets what it can't reach — visceral adipose tissue, the deep abdominal fat that doesn't respond to appetite suppression. A GHRH analogue that stimulates the pituitary to release its own growth hormone. The protocol for the GLP-1 graduate.
Methionine, Inositol, Choline, Cyanocobalamin. A compounded lipotropic injection that supports liver fat processing and metabolic function during caloric restriction. Commonly stacked with GLP-1 to enhance body composition outcomes and support the liver during active fat loss.
Your intake takes five minutes. Provider review within 48 hours. No waiting room. No contracts. No guesswork.
